$3.93
4.16%
Nasdaq, Sep 02, 05:48 pm CET

BioNano Genomics, Inc. Stock price

$3.77
+0.69 22.40% 1M
-0.39 9.38% 6M
-13.53 78.21% YTD
-25.22 87.00% 1Y
-1,457.23 99.74% 3Y
-361.39 98.97% 5Y
-4,190.23 99.91% 10Y
-4,190.23 99.91% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.08 2.08%

Key metrics

Basic
Market capitalization
$17.7m
Enterprise Value
$5.0m
Net debt
positive
Cash
$16.4m
Shares outstanding
3.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.6
EV/Sales
0.2 | 0.2
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
46.1%
Return on Equity
-316.7%
ROCE
-97.8%
ROIC
-127.4%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$27.4m | $29.3m
EBITDA
$-37.7m | $-13.6m
EBIT
$-50.7m | $-30.3m
Net Income
$-74.3m | $-29.0m
Free Cash Flow
$-26.1m
Growth (TTM | estimate)
Revenue
-25.0% | -4.8%
EBITDA
58.1% | 80.5%
EBIT
50.9% | 60.3%
Net Income
63.6% | 74.1%
Free Cash Flow
75.4%
Margin (TTM | estimate)
Gross
5.1%
EBITDA
-137.3% | -46.5%
EBIT
-184.8%
Net
-271.0% | -99.1%
Free Cash Flow
-95.0%
More
EPS
$-21.6
FCF per Share
$-6.7
Short interest
8.5%
Employees
99
Rev per Employee
$310.0k
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BioNano Genomics, Inc. forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a BioNano Genomics, Inc. forecast:

Buy
70%
Hold
30%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
27 27
25% 25%
100%
- Direct Costs 26 26
0% 0%
95%
1.39 1.39
87% 87%
5%
- Selling and Administrative Expenses 39 39
46% 46%
141%
- Research and Development Expense 13 13
68% 68%
49%
-38 -38
58% 58%
-137%
- Depreciation and Amortization 13 13
3% 3%
48%
EBIT (Operating Income) EBIT -51 -51
51% 51%
-185%
Net Profit -74 -74
64% 64%
-271%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
GlobeNewsWire
8 days ago
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8th, 2025.
Neutral
Seeking Alpha
18 days ago
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Robert Erik Holmlin - President, CEO, CFO & Director Conference Call Participants Michael Okunewitch - Maxim Group LLC, Research Division Vidyun Bais - BTIG, LLC, Research Division Yi Chen - H.C. Wainwright & Co, LLC, Research Division Kelly Gura - Unidentified Company Investor...
Neutral
GlobeNewsWire
19 days ago
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of focusing on our base of routine users of optical genome mapping (OGM) and VIA™ software as the primary drivers of our revenue and gross profit in the second quarter.
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 99
Founded 2003
Website bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today